California Constitution Article XXXV - Medical Research [Sections 1 - 7]
Here is a summary of the California Constitution – Article XXXV: Medical Research
[Sections 1 – 7]
🧬 Purpose of Article XXXV
Added by Proposition 71 in 2004, Article XXXV authorizes and governs state-funded stem cell research, including embryonic stem cell research, by establishing a legal and financial framework to support medical breakthroughs and regenerative medicine in California.
📘 Section-by-Section Summary:
Section 1 – Right to Conduct Stem Cell Research
Affirms the right of California to conduct and fund stem cell research, including research involving human embryonic stem cells, adipose tissue, placenta, and umbilical cord blood.
Ensures research is done ethically, responsibly, and with public accountability.
Section 2 – Creation of the California Institute for Regenerative Medicine (CIRM)
Establishes the California Institute for Regenerative Medicine (CIRM).
CIRM is responsible for administering grants and loans to fund research and facilities related to stem cells and regenerative medicine.
Operates independently of direct legislative control.
Section 3 – Governing Body (Independent Citizens’ Oversight Committee - ICOC)
Creates the Independent Citizens’ Oversight Committee (ICOC) to govern CIRM.
ICOC includes appointed representatives from UC campuses, non-profits, private industry, and patient advocacy groups.
Manages oversight of funding, ethics, and accountability.
Section 4 – Research Funding and Bond Authorization
Authorizes the state to issue up to $3 billion in bonds to finance stem cell research and related infrastructure.
Funding is specifically dedicated to medical research, facilities, and therapy development.
Section 5 – Limitation on State Liability
Clarifies that the State of California is not liable for the debts or obligations of CIRM beyond the amount provided through voter-approved bonds.
Section 6 – Use of Funds
Requires that funds be used only for purposes stated in the proposition, including:
Research,
Facilities,
Therapy development,
Public education and oversight.
Section 7 – Severability Clause
If any part of this article is found invalid, the remainder shall remain in full effect.
✅ Summary of Intent:
Promote cutting-edge medical research.
Position California as a leader in biotechnology and regenerative medicine.
Establish CIRM as an independent, scientifically driven funding agency.
Maintain public oversight, ethics, and transparency in medical research.
RELATED Blog
0 comments